{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:09:58Z","timestamp":1787238598512,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Brain structural abnormalities are often observed on magnetic resonance imaging (MRI) scans of Cushing's syndrome patients, but the pathogenesis is not fully understood. To understand the relationship between brain structural abnormalities and potential risk factors in active Cushing's disease (CD) patients, a total of 101 treatment-na\u00efve CD patients and 95 sex-, age- and education matched controls with non-functioning adenomas (NFA) underwent clinical evaluation and MRI investigation, and the relative risk factors were analyzed. 14 patients in sustained remission after transsphenoidal surgery were followed. Compared with the NFA subjects, the patients with CD had more cortical (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.01) and subcortical atrophy (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.01) and a higher prevalence of white matter hyperintensity (WMH) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.01). WMH severity in CD patients positively correlated with age (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.532,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.000), disease course (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.257,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.009), postprandial glucose (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.278,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.005), frequency of left ventricular hypertrophy (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.398,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001) and hypothyroidism (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.246,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.014). The markers of cortical and subcortical atrophy (sylvian fissure ratio, bifrontal ratio, bicaudate ratio and third ventricle width) were positively associated with the progression of WMH in the CD patients. In the follow-up of 14 patients with CD, brain atrophy and WMH was partially reversible after correction of hypercortisolism. In conclusions, brain atrophy and WMH were more likely to appear in CD patients and were possibly partially reversible following correction of hypercortisolism.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-68166-0","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T06:04:12Z","timestamp":1596002652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Detrimental effects of hypercortisolism on brain structure and related risk factors"],"prefix":"10.1038","volume":"10","author":[{"given":"Yaxi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"68166_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2003.09.010","volume":"55","author":"ES Brown","year":"2004","unstructured":"Brown, E. S. et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 55, 538\u2013545 (2004).","journal-title":"Biol. Psychiatry"},{"key":"68166_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0893-133X(99)00054-8","volume":"21","author":"ES Brown","year":"1999","unstructured":"Brown, E. S., Rush, A. J. & McEwen, B. S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 21, 474\u2013484 (1999).","journal-title":"Neuropsychopharmacology"},{"key":"68166_CR3","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/eje-14-1101","volume":"173","author":"CD Andela","year":"2015","unstructured":"Andela, C. D. et al. Mechanisms in endocrinology: Cushing\u2019s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. Eur. J. Endocrinol. 173, R1-14. https:\/\/doi.org\/10.1530\/eje-14-1101 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"68166_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman, M. N., Gebarski, S. S., Berent, S. & Schteingart, D. E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome. Biol. Psychiat. 32, 756\u2013765 (1992).","journal-title":"Biol. Psychiat."},{"key":"68166_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1210\/jc.2011-2231","volume":"97","author":"E Resmini","year":"2012","unstructured":"Resmini, E. et al. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 97, 663\u2013671. https:\/\/doi.org\/10.1210\/jc.2011-2231 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68166_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0006-3223(99)00203-6","volume":"46","author":"MN Starkman","year":"1999","unstructured":"Starkman, M. N. et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing\u2019s disease. Biol. Psychiat. 46, 1595\u20131602 (1999).","journal-title":"Biol. Psychiat."},{"key":"68166_CR7","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1210\/jc.2004-2488","volume":"90","author":"DP Merke","year":"2005","unstructured":"Merke, D. P. et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J. Clin. Endocrinol. Metab. 90, 2531\u20132536. https:\/\/doi.org\/10.1210\/jc.2004-2488 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68166_CR8","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1210\/jc.2009-0766","volume":"94","author":"MJ Barahona","year":"2009","unstructured":"Barahona, M. J. et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab 94, 3365\u20133371 (2009).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"68166_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2018.11498","volume":"320","author":"W Williamson","year":"2018","unstructured":"Williamson, W. et al. Association of cardiovascular risk factors with MRI indices of cerebrovascular structure and function and white matter hyperintensities in young adults. JAMA 320, 665\u2013673 (2018).","journal-title":"JAMA"},{"key":"68166_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.nicl.2014.01.017","volume":"4","author":"SJ van der Werff","year":"2014","unstructured":"van der Werff, S. J. et al. Widespread reductions of white matter integrity in patients with long-term remission of Cushing\u2019s disease. NeuroImage Clin. 4, 659\u2013667. https:\/\/doi.org\/10.1016\/j.nicl.2014.01.017 (2014).","journal-title":"NeuroImage Clin."},{"key":"68166_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3174\/ajnr.A4322","volume":"36","author":"P Pires","year":"2015","unstructured":"Pires, P. et al. White matter alterations in the brains of patients with active, remitted, and cured cushing syndrome: a DTI study. AJNR Am. J. Neuroradiol. 36, 1043\u20131048. https:\/\/doi.org\/10.3174\/ajnr.A4322 (2015).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"68166_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11102-017-0793-y","volume":"20","author":"P Pires","year":"2017","unstructured":"Pires, P. et al. White matter involvement on DTI-MRI in Cushing\u2019s syndrome relates to mood disturbances and processing speed: a case-control study. Pituitary 20, 340\u2013348. https:\/\/doi.org\/10.1007\/s11102-017-0793-y (2017).","journal-title":"Pituitary"},{"key":"68166_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainres.2017.04.007","volume":"1665","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. Altered gray and white matter microstructure in Cushing\u2019s disease: a diffusional kurtosis imaging study. Brain Res. 1665, 80\u201387. https:\/\/doi.org\/10.1016\/j.brainres.2017.04.007 (2017).","journal-title":"Brain Res."},{"key":"68166_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1530\/eje-15-0600","volume":"173","author":"A Santos","year":"2015","unstructured":"Santos, A. et al. Cardiovascular risk and white matter lesions after endocrine control of Cushing\u2019s syndrome. Eur. J. Endocrinol. 173, 765\u2013775. https:\/\/doi.org\/10.1530\/eje-15-0600 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"68166_CR15","doi-asserted-by":"publisher","first-page":"e19859","DOI":"10.1371\/journal.pone.0019859","volume":"6","author":"S Miyata","year":"2011","unstructured":"Miyata, S. et al. Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum. PLoS ONE 6, e19859 (2011).","journal-title":"PLoS ONE"},{"key":"68166_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000443868","volume":"46","author":"E Resmini","year":"2016","unstructured":"Resmini, E., Santos, A. & Webb, S. M. Cortisol Excess and the Brain. Front. Horm. Res. 46, 74\u201386. https:\/\/doi.org\/10.1159\/000443868 (2016).","journal-title":"Front. Horm. Res."},{"key":"68166_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1192\/bjp.136.2.120","volume":"136","author":"SI Cohen","year":"1980","unstructured":"Cohen, S. I. Cushing\u2019s syndrome: a psychiatric study of 29 patients. Br. J. Psychiatry 136, 120\u2013124 (1980).","journal-title":"Br. J. Psychiatry"},{"key":"68166_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","volume":"45","author":"WF Kelly","year":"1996","unstructured":"Kelly, W. F., Kelly, M. J. & Faragher, B. A prospective study of psychiatric and psychological aspects of Cushing\u2019s syndrome. Clin. Endocrinol. 45, 715\u2013720 (1996).","journal-title":"Clin. Endocrinol."},{"key":"68166_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-8993(90)90778-A","volume":"531","author":"CS Woolley","year":"1990","unstructured":"Woolley, C. S., Gould, E. & McEwen, B. S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531, 225\u2013231 (1990).","journal-title":"Brain Res."},{"key":"68166_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jpsychires.2007.10.003","volume":"42","author":"MI Schubert","year":"2008","unstructured":"Schubert, M. I. et al. Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure\u2013an in vivo magnetic resonance spectroscopy and imaging study. J. Psychiatr. Res. 42, 902\u2013912. https:\/\/doi.org\/10.1016\/j.jpsychires.2007.10.003 (2008).","journal-title":"J. Psychiatr. Res."},{"key":"68166_CR21","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/01.STR.27.8.1274","volume":"27","author":"WT Longstreth","year":"1996","unstructured":"Longstreth, W. T. et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27, 1274\u20131282 (1996).","journal-title":"Stroke"},{"key":"68166_CR22","doi-asserted-by":"publisher","first-page":"108457","DOI":"10.1016\/j.steroids.2019.108457","volume":"151","author":"H Jiang","year":"2019","unstructured":"Jiang, H. et al. Reversible and the irreversible structural alterations on brain after resolution of hypercortisolism in Cushing\u2019s disease. Steroids 151, 108457. https:\/\/doi.org\/10.1016\/j.steroids.2019.108457 (2019).","journal-title":"Steroids"},{"key":"68166_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1365-2265.1990.tb03915.x","volume":"33","author":"G Benker","year":"1990","unstructured":"Benker, G. et al. TSH secretion in Cushing\u2019s syndrome: relation to glucocorticoid excess, diabetes, goitre, and the \u201csick euthyroid syndrome\u201d. Clin. Endocrinol. 33, 777\u2013786 (1990).","journal-title":"Clin. Endocrinol."},{"key":"68166_CR24","first-page":"535","volume":"11","author":"EL Constant","year":"2005","unstructured":"Constant, E. L. et al. Anxiety and depression, attention, and executive functions in hypothyroidism. JINS 11, 535\u2013544 (2005).","journal-title":"JINS"},{"key":"68166_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1532-5415.1992.tb02130.x","volume":"40","author":"D Osterweil","year":"1992","unstructured":"Osterweil, D. et al. Cognitive function in non-demented older adults with hypothyroidism. J. Am. Geriat. Soc. 40, 325\u2013335 (1992).","journal-title":"J. Am. Geriat. Soc."},{"key":"68166_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689\u2013701. https:\/\/doi.org\/10.1016\/s1474-4422(10)70104-6 (2010).","journal-title":"Lancet Neurol."},{"key":"68166_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5853\/jos.2017.02922","volume":"20","author":"E Cuadrado-Godia","year":"2018","unstructured":"Cuadrado-Godia, E. et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. J. Stroke 20, 302\u2013320 (2018).","journal-title":"J. Stroke"},{"key":"68166_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","volume":"33","author":"AM Isidori","year":"2015","unstructured":"Isidori, A. M. et al. The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J. Hypertens. 33, 44\u201360 (2015).","journal-title":"J. Hypertens."},{"key":"68166_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1212\/WNL.0000000000001205","volume":"84","author":"H Arima","year":"2015","unstructured":"Arima, H. et al. Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2. Neurology 84, 464\u2013471 (2015).","journal-title":"Neurology"},{"key":"68166_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/jch.13232","volume":"20","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi, S., Vernieri, F. & Silvestrini, M. Blood pressure variability and neurocognitive functioning. J. Clin. Hypertens. (Greenwich Conn.) 20, 645\u2013647 (2018).","journal-title":"J. Clin. Hypertens. (Greenwich Conn.)"},{"key":"68166_CR31","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1212\/WNL.0000000000004862","volume":"90","author":"S Lattanzi","year":"2018","unstructured":"Lattanzi, S. et al. Neurocognitive functioning and cerebrovascular reactivity after carotid endarterectomy. Neurology 90, e307\u2013e315 (2018).","journal-title":"Neurology"},{"key":"68166_CR32","doi-asserted-by":"crossref","unstructured":"1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J. Hypertens. 17, 151\u2013183 (1999).","DOI":"10.1097\/00004872-199917020-00001"},{"key":"68166_CR33","first-page":"3617","volume":"80","author":"PM Stewart","year":"1995","unstructured":"Stewart, P. M., Walker, B. R., Holder, G. E., O\u2019Halloran, D. O. & Shackleton, C. H. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing\u2019s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J. Clin. Endocrinol. Metab. 80, 3617\u20133620 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68166_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","volume":"13","author":"FJ Frey","year":"2004","unstructured":"Frey, F. J., Odermatt, A. & Frey, B. M. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr. Opin. Nephrol. Hypertens. 13, 451\u2013458 (2004).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"68166_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.yfrne.2010.12.001","volume":"32","author":"CS Wyrwoll","year":"2011","unstructured":"Wyrwoll, C. S., Holmes, M. C. & Seckl, J. R. 11\u03b2-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front. Neuroendocrinol. 32, 265\u2013286 (2011).","journal-title":"Front. Neuroendocrinol."},{"key":"68166_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1749-6632.1994.tb39247.x","volume":"746","author":"RM Sapolsky","year":"1994","unstructured":"Sapolsky, R. M. The physiological relevance of glucocorticoid endangerment of the hippocampusa. Ann. N. Y. Acad. Sci. 746, 294\u2013304. https:\/\/doi.org\/10.1111\/j.1749-6632.1994.tb39247.x (1994).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"68166_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fphar.2017.00313","volume":"8","author":"GH Tesch","year":"2017","unstructured":"Tesch, G. H. & Young, M. J. Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis. Front. Pharmacol. 8, 313. https:\/\/doi.org\/10.3389\/fphar.2017.00313 (2017).","journal-title":"Front. Pharmacol."},{"key":"68166_CR38","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1073\/pnas.1520376113","volume":"113","author":"A Mahfouz","year":"2016","unstructured":"Mahfouz, A. et al. Genome-wide coexpression of steroid receptors in the mouse brain: Identifying signaling pathways and functionally coordinated regions. Proc. Natl. Acad. Sci. USA 113, 2738\u20132743. https:\/\/doi.org\/10.1073\/pnas.1520376113 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68166_CR39","doi-asserted-by":"publisher","first-page":"R1754","DOI":"10.1152\/ajpregu.00145.2007","volume":"293","author":"CS Rigsby","year":"2007","unstructured":"Rigsby, C. S., Burch, A. E., Ogbi, S., Pollock, D. M. & Dorrance, A. M. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists. Am. J. Physiol. Regul. Integr. Compar. Physiol. 293, R1754\u2013R1763. https:\/\/doi.org\/10.1152\/ajpregu.00145.2007 (2007).","journal-title":"Am. J. Physiol. Regul. Integr. Compar. Physiol."},{"key":"68166_CR40","doi-asserted-by":"publisher","first-page":"109695","DOI":"10.1016\/j.biopha.2019.109695","volume":"122","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Yu, Y., Qiao, J., Zhu, L. & Xiao, Z. Mineralocorticoid receptor excessive activation involved in glucocorticoid-related brain injury. Biomed. Pharmacother. 122, 109695. https:\/\/doi.org\/10.1016\/j.biopha.2019.109695 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"68166_CR41","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman, L. K. et al. The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68166_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KGMM Alberti","year":"1998","unstructured":"Alberti, K. G. M. M. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab. Med. 15, 539\u2013553 (1998).","journal-title":"Diab. Med."},{"key":"68166_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/adr-170013","volume":"1","author":"N Sheikh-Bahaei","year":"2017","unstructured":"Sheikh-Bahaei, N., Sajjadi, S. A., Manavaki, R. & Gillard, J. H. Imaging biomarkers in Alzheimer\u2019s disease: a practical guide for clinicians. J. Alzheimer\u2019s Dis. Rep. 1, 71\u201388. https:\/\/doi.org\/10.3233\/adr-170013 (2017).","journal-title":"J. Alzheimer's Dis. Rep."},{"key":"68166_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF00328197","volume":"26","author":"JM Gomori","year":"1984","unstructured":"Gomori, J. M., Steiner, I., Melamed, E. & Cooper, G. The assessment of changes in brain volume using combined linear measurements. Neuroradiology 26, 21\u201324. https:\/\/doi.org\/10.1007\/BF00328197 (1984).","journal-title":"Neuroradiology"},{"key":"68166_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.archger.2006.04.006","volume":"44","author":"E Saka","year":"2007","unstructured":"Saka, E., Dogan, E. A., Topcuoglu, M. A., Senol, U. & Balkan, S. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer\u2019s disease (AD). Arch. Gerontol. Geriatr. 44, 141\u2013151. https:\/\/doi.org\/10.1016\/j.archger.2006.04.006 (2007).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"68166_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. & Zimmerman, R. A. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR 149, 351\u2013356. https:\/\/doi.org\/10.2214\/ajr.149.2.351 (1987).","journal-title":"AJR"},{"key":"68166_CR47","doi-asserted-by":"publisher","first-page":"e001140","DOI":"10.1161\/JAHA.114.001140","volume":"4","author":"JM Wardlaw","year":"2015","unstructured":"Wardlaw, J. M., Vald\u00e9s Hern\u00e1ndez, M. C. & Mu\u00f1oz-Maniega, S. What are white matter hyperintensities made of? relevance to vascular cognitive impairment. J. Am. Heart Assoc. 4, e001140 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"68166_CR48","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2337\/diabetes.55.04.06.db05-1323","volume":"55","author":"SM Manschot","year":"2006","unstructured":"Manschot, S. M. et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55, 1106\u20131113. https:\/\/doi.org\/10.2337\/diabetes.55.04.06.db05-1323 (2006).","journal-title":"Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68166-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68166-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68166-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T10:18:42Z","timestamp":1670321922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68166-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68166"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68166-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"17 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12708"}}